Podcast
Author(s):
Arthur Kuan, CEO of CG Oncology, talks about the present and future of bladder cancer therapies, and how he’s committed to making a difference.
Arthur Kuan, CEO of CG Oncology, discusses bladder cancer therapies and how his company is contributing to the fight.
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.